Your browser doesn't support javascript.
loading
Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota.
Chandra Deb, Liton; Hove, Hannah; Miller, Tracy K; Pinks, Kodi; Njau, Grace; Hagan, John J; Jansen, Rick J.
Afiliación
  • Chandra Deb L; Department of Public Health, North Dakota State University, Fargo, ND, United States of America.
  • Hove H; Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, United States of America.
  • Miller TK; Department of Public Health, North Dakota State University, Fargo, ND, United States of America.
  • Pinks K; University of North Dakota School of Medicine & Health Sciences, Grand Forks, ND, United States of America.
  • Njau G; North Dakota Department of Health, Bismarck, ND, United States of America.
  • Hagan JJ; North Dakota Department of Health, Bismarck, ND, United States of America.
  • Jansen RJ; North Dakota Department of Health, Bismarck, ND, United States of America.
PLoS One ; 17(3): e0266047, 2022.
Article en En | MEDLINE | ID: mdl-35349606
ABSTRACT
This retrospective cohort study was conducted to determine the prevalence of HCV infections among individuals incarcerated in a state prison system and identify potential contributing factors to HCV infection. North Dakota Department of Corrections and Rehabilitation (NDDOCR) data from 2009 to 2018 was used and period prevalence was calculated for this 10-year time period. The period prevalence of HCV infection was (15.13% (95% CI 14.39-15.90) with a marginally significant (p-value 0.0542) increasing linear trend in annual prevalence over this period. Multivariate logistic regression analysis was used to identify risk factors associated with HCV infection. The main significant independent risk factors for HCV infection in this incarcerated population were age >40 years [OR 1.78 (1.37-2.32)]; sex [OR 1.21 (1.03-1.43)]; race/ethnicity [OR 1.97 (1.69-2.29)]; history of intravenous drug use (IVDU) [OR 7.36 (6.41-8.44)]; history of needle or syringe sharing [OR 7.57 (6.62-8.67)]; and alcohol use [OR 0.87 (0.77-0.99)]. Study limitations include uncollected information on sexual history, frequency or duration of injection drug use and blood transfusion history of the incarcerated population. Considering the high prevalence of HCV infection and its associated risk factors, it is important to implement prevention programs such as syringe/needle exchanges and counsel with imprisoned IVD users.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Prisioneros / Abuso de Sustancias por Vía Intravenosa / Hepatitis C Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Región como asunto: America do norte Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Prisioneros / Abuso de Sustancias por Vía Intravenosa / Hepatitis C Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Región como asunto: America do norte Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article